65 /100
HIGH RISK
Score updated Apr 13, 2026

NWBO

Northwest Biotherapeutics, Inc. — Stock Dilution Tracker

Track NWBO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track NWBO — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 70%
• 50-day avg $0.23 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 2.2 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track NWBO — Get forecast alerts →
💹 Market Data
Market Cap$308.14M
Shares Outstanding1.54B
Float1.51B
Cash$4.56M
Debt$77.05M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 69.9% shares (2025Q4 vs prior)
7 institutional holders · 217.9K shares
#1 VSM Wealth Advisory, LLC 80.6K shares
#2 Opus Capital Group, LLC 60.1K shares
#3 Ethos Financial Group, LLC 28.4K shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest62.28M
Days to Cover11.7
% of Float4.1%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2024
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track NWBO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NWBO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required